$2.08
00.00%
Pre-Market: 7:00 AM EDT
15 minutes delayed
Immix Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immix Biopharma using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IMMX | Immix Biopharma | -$0.24 | -$0.21 | — | — | $0.00 | — | — | — | 08/09/2024 | Get Alert |
IMMX | Immix Biopharma | -$0.18 | -$0.23 | -$0.22 | 4.35% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
IMMX | Immix Biopharma | -$0.27 | -$0.23 | -$0.24 | -4.35% | $0.00 | — | $0.00 | — | 03/29/2024 | Get Alert |
IMMX | Immix Biopharma | -$0.11 | -$0.23 | -$0.23 | 0.00% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
IMMX | Immix Biopharma | -$0.11 | -$0.17 | -$0.24 | -41.18% | $0.00 | — | $0.00 | — | 08/11/2023 | Get Alert |
IMMX | Immix Biopharma | -$0.10 | -$0.14 | -$0.18 | -28.57% | $0.00 | — | $0.00 | — | 05/12/2023 | Get Alert |
IMMX | Immix Biopharma | — | -$0.22 | -$0.27 | -22.73% | — | — | $0.00 | — | 03/27/2023 | Get Alert |
IMMX | Immix Biopharma | — | — | -$0.11 | — | — | — | $0.00 | — | 11/09/2022 | Get Alert |
IMMX | Immix Biopharma | -$0.06 | — | -$0.11 | — | $0.00 | — | $0.00 | — | 08/12/2022 | Get Alert |
IMMX | Immix Biopharma | -$0.30 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/13/2022 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.22 | $-0.23 | 4.35 % |
Dec 2023 | 2024-03-29 | $-0.24 | $-0.23 | -4.35 % |
Sep 2023 | 2023-11-13 | $-0.23 | $-0.23 | 0.00 % |
Jun 2023 | 2023-08-11 | $-0.24 | $-0.17 | -41.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Immix Biopharma (IMMX) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.22, which beat the estimate of $-0.23.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.